Voyageur Pharmaceuticals Ltd.
VM.V
TSX
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Net Income | -460.10K | -620.30K | -951.20K | -387.10K | -571.30K |
| Total Depreciation and Amortization | 200.00 | 200.00 | 200.00 | 200.00 | 200.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 26.20K | -83.40K | 172.40K | 202.80K | 282.70K |
| Change in Net Operating Assets | 312.60K | 438.50K | 134.70K | -1.30K | -430.50K |
| Cash from Operations | -121.10K | -265.00K | -643.90K | -185.40K | -718.90K |
| Capital Expenditure | -19.20K | -65.90K | -83.90K | -14.60K | -29.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -19.20K | -65.90K | -83.90K | -14.60K | -29.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 12.80K | 1.63M | 90.20K | 1.61M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -226.90K | -68.70K | -69.50K | -66.10K |
| Cash from Financing | -- | -153.40K | 1.14M | 14.70K | 1.08M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | 0.00 | 0.00 | 0.00 | -- |
| Net Change in Cash | -140.30K | -484.30K | 411.70K | -185.30K | 330.80K |